Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic plasticity and the hallmarks of cancer
William Flavahan, Elizabeth Gaskell, B Bernstein
Science (2017) Vol. 357, Iss. 6348
Open Access | Times Cited: 1150

Showing 1-25 of 1150 citing articles:

Hallmarks of Cancer: New Dimensions
Douglas Hanahan
Cancer Discovery (2022) Vol. 12, Iss. 1, pp. 31-46
Open Access | Times Cited: 3290
Molecular principles of metastasis: a hallmark of cancer revisited
Jawad Fares, Mohamad Y. Fares, Hussein H. Khachfe, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1789
From chemotherapy to biological therapy: A review of novel concepts to reduce the side effects of systemic cancer treatment (Review)
Volker Schirrmacher
International Journal of Oncology (2018) Vol. 54, Iss. 2, pp. 407-419
Open Access | Times Cited: 1090
The chromatin accessibility landscape of primary human cancers
M. Ryan Corces, Jeffrey M. Granja, Shadi Shams, et al.
Science (2018) Vol. 362, Iss. 6413
Open Access | Times Cited: 1039
Intratumor Heterogeneity: The Rosetta Stone of Therapy Resistance
Andriy Marusyk, Michalina Janiszewska, Kornélia Polyák
Cancer Cell (2020) Vol. 37, Iss. 4, pp. 471-484
Open Access | Times Cited: 719
Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity
Shannon Lee, Jens Rauch, Walter Kölch
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 3, pp. 1102-1102
Open Access | Times Cited: 637
Genetics and biology of prostate cancer
Guocan Wang, Di Zhao, Denise J. Spring, et al.
Genes & Development (2018) Vol. 32, Iss. 17-18, pp. 1105-1140
Open Access | Times Cited: 634
METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
Ting Li, Pei-Shan Hu, Zhixiang Zuo, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 633
LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade
Wanqiang Sheng, Martin W. LaFleur, Thao H. Nguyen, et al.
Cell (2018) Vol. 174, Iss. 3, pp. 549-563.e19
Open Access | Times Cited: 573
Intratumoral heterogeneity in cancer progression and response to immunotherapy
Ilio Vitale, Efrat Shema, Sherene Loi, et al.
Nature Medicine (2021) Vol. 27, Iss. 2, pp. 212-224
Closed Access | Times Cited: 567
The Next Decade of Immune Checkpoint Therapy
Padmanee Sharma, Bilal A. Siddiqui, Swetha Anandhan, et al.
Cancer Discovery (2021) Vol. 11, Iss. 4, pp. 838-857
Open Access | Times Cited: 544
Non-genetic mechanisms of therapeutic resistance in cancer
Jean‐Christophe Marine, Sarah‐Jane Dawson, Mark A. Dawson
Nature reviews. Cancer (2020) Vol. 20, Iss. 12, pp. 743-756
Closed Access | Times Cited: 439
Glucose transporters in cancer – from tumor cells to the tumor microenvironment
Pierre‐Benoit Ancey, Caroline Contat, Etienne Meylan
FEBS Journal (2018) Vol. 285, Iss. 16, pp. 2926-2943
Open Access | Times Cited: 437
Overcoming cancer therapeutic bottleneck by drug repurposing
Zhe Zhang, Li Zhou, Na Xie, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 429
Heterochromatin: Guardian of the Genome
Aniek Janssen, Serafin U. Colmenares, Gary H. Karpen
Annual Review of Cell and Developmental Biology (2018) Vol. 34, Iss. 1, pp. 265-288
Open Access | Times Cited: 426
Cancer epigenetics: Moving forward
Angela Nebbioso, Francesco Paolo Tambaro, Carmela Dell’Aversana, et al.
PLoS Genetics (2018) Vol. 14, Iss. 6, pp. e1007362-e1007362
Open Access | Times Cited: 415
LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
Yun Wang, Jia-Huan Lu, Qi-Nian Wu, et al.
Molecular Cancer (2019) Vol. 18, Iss. 1
Open Access | Times Cited: 413
Methionine metabolism in health and cancer: a nexus of diet and precision medicine
Sydney M. Sanderson, Xia Gao, Ziwei Dai, et al.
Nature reviews. Cancer (2019) Vol. 19, Iss. 11, pp. 625-637
Closed Access | Times Cited: 396
The evolving metabolic landscape of chromatin biology and epigenetics
Ziwei Dai, Vijyendra Ramesh, Jason W. Locasale
Nature Reviews Genetics (2020) Vol. 21, Iss. 12, pp. 737-753
Open Access | Times Cited: 359
Bridging Bio–Nano Science and Cancer Nanomedicine
Mattias Björnmalm, Kristofer J. Thurecht, Michael Michael, et al.
ACS Nano (2017) Vol. 11, Iss. 10, pp. 9594-9613
Open Access | Times Cited: 352
Evaluating intrinsic and non-intrinsic cancer risk factors
Song Wu, Wei Zhu, Patricia Thompson, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 338
The causes of evolvability and their evolution
Joshua L. Payne, Andreas Wagner
Nature Reviews Genetics (2018) Vol. 20, Iss. 1, pp. 24-38
Open Access | Times Cited: 323
Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics
Anna S. Nam, Ronan Chaligné, Dan A. Landau
Nature Reviews Genetics (2020) Vol. 22, Iss. 1, pp. 3-18
Open Access | Times Cited: 310
Histone H2AK119 Mono-Ubiquitination Is Essential for Polycomb-Mediated Transcriptional Repression
Simone Tamburri, Elisa Lavarone, Daniel Fernández-Pérez, et al.
Molecular Cell (2019) Vol. 77, Iss. 4, pp. 840-856.e5
Open Access | Times Cited: 298
The language of chromatin modification in human cancers
Shuai Zhao, C. David Allis, Gang Greg Wang
Nature reviews. Cancer (2021) Vol. 21, Iss. 7, pp. 413-430
Open Access | Times Cited: 293
Page 1 - Next Page

Scroll to top